You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
南韩新增3宗接种阿斯利康疫苗後死亡个案 累计增至5宗
阿思达克 03-04 15:31
《韩联社》报道,南韩今日(4日)新增3宗接种阿斯利康(AZN.US)疫苗後死亡个案,当中2宗发生在全罗北道的疗养院,1宗来自大田市一家残疾人设施,3人生前均接种过阿斯利康疫苗。当局正在开展流行病学调查,以确认3人的死因是否与预防接种等有关。

全罗北道两名男死者年龄为50多岁男性,且患有基础疾病,其中一人生前患有心脑血管疾病,另一人患有心肌梗塞和糖尿病等疾病,分别於接种疫苗後41小时及15小时後离世。另外大田市的死者为一名20多岁女性,於3月2日接种,15个小时後去世。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account